MedPath

Far Infrared Radiation Treatment for Diabetes

Phase 1
Conditions
Diabetes Mellitus
Interventions
Radiation: Far Infrared Radiation
Registration Number
NCT00573456
Lead Sponsor
GAAD Medical Research Institute Inc.
Brief Summary

A study to determine the use of far infrared (FIR) radiation for treatment of diabetes.

Detailed Description

Diabetes mellitus is a disease in which glucose is not sufficiently metabolized. This results in high glucose levels in blood and glucose in the urine. Cells can starve because glucose is not being metabolized.

Both types of diabetes can cause dangerous complications, including blindness, heart and blood vessel disease, and kidney failure. A decrease in circulation may eventually require the amputation of limbs.

We are postulating that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby improving the health of the patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Persons with type 1 or type 2 diabetes
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Far Infrared Radiation-
Primary Outcome Measures
NameTimeMethod
The primary end point is to determine the therapeutic effects of far infrared radiation on all types of diabetes.2 years
Secondary Outcome Measures
NameTimeMethod
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other types of diabetes complications including blindness, heart and blood vessel disease and kidney failure.2 years

Trial Locations

Locations (1)

The Centre for Incurable Diseases

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath